1. Home
  2. RCKT vs MEI Comparison

RCKT vs MEI Comparison

Compare RCKT & MEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • MEI
  • Stock Information
  • Founded
  • RCKT 1999
  • MEI 1946
  • Country
  • RCKT United States
  • MEI United States
  • Employees
  • RCKT N/A
  • MEI N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • MEI Electrical Products
  • Sector
  • RCKT Health Care
  • MEI Technology
  • Exchange
  • RCKT Nasdaq
  • MEI Nasdaq
  • Market Cap
  • RCKT 328.6M
  • MEI 286.7M
  • IPO Year
  • RCKT N/A
  • MEI N/A
  • Fundamental
  • Price
  • RCKT $3.17
  • MEI $7.53
  • Analyst Decision
  • RCKT Buy
  • MEI Buy
  • Analyst Count
  • RCKT 13
  • MEI 2
  • Target Price
  • RCKT $12.88
  • MEI $11.25
  • AVG Volume (30 Days)
  • RCKT 2.3M
  • MEI 458.6K
  • Earning Date
  • RCKT 11-06-2025
  • MEI 09-09-2025
  • Dividend Yield
  • RCKT N/A
  • MEI 3.75%
  • EPS Growth
  • RCKT N/A
  • MEI N/A
  • EPS
  • RCKT N/A
  • MEI N/A
  • Revenue
  • RCKT N/A
  • MEI $1,030,100,000.00
  • Revenue This Year
  • RCKT N/A
  • MEI N/A
  • Revenue Next Year
  • RCKT $108.43
  • MEI $3.55
  • P/E Ratio
  • RCKT N/A
  • MEI N/A
  • Revenue Growth
  • RCKT N/A
  • MEI N/A
  • 52 Week Low
  • RCKT $2.19
  • MEI $5.08
  • 52 Week High
  • RCKT $18.89
  • MEI $17.45
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 48.26
  • MEI 45.23
  • Support Level
  • RCKT $3.13
  • MEI $7.37
  • Resistance Level
  • RCKT $3.44
  • MEI $8.37
  • Average True Range (ATR)
  • RCKT 0.17
  • MEI 0.33
  • MACD
  • RCKT -0.01
  • MEI -0.04
  • Stochastic Oscillator
  • RCKT 35.11
  • MEI 8.70

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About MEI Methode Electronics Inc.

Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.

Share on Social Networks: